Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Ribociclib
by Most News Heat in the world in 2019

The Ribociclib top 10 is Discovery PatSnap’ annual ranking of the top 10 Most News Heat Ribociclib Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Ribociclib (trade name Kisqali) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is also being studied as a treatment for other drug-resistant cancers. It was developed by Novartis and Astex Pharmaceuticals.
#
Company Name
Region
Tech Topics
Total
1
Gene,Health care,Cell therapy,
...[+2]
news: 2
2
Perelman Apps
Auckland, New Zealand
news: 2
3
news: 1
4
Medicine,Pharmacy and Therapeutics,Amyloidosis,
...[+2]
news: 1
5
Gene,Medicine,Health care,
...[+2]
news: 1
6
Ribon Ltda
São Paulo, Brazil
Donation,Blockchain,Social influence,
...[+2]
news: 1
7
Kanagawa, Japan
news: 1
8
Medical equipment,Health care,Pharmacy and Therapeutics,
...[+2]
news: 1
9
UK Government Investments Ltd.
United Kingdom
news: 1
10
Juno Residential, Inc.
Real estate development,Real estate,Prefabrication
news: 1
Page generation time: Jul 07 2025